Saito R, Sugawara S, Ko R, Azuma K, et al. Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study. Eur J Cancer 2023;185:83-93.
PMID: 36966696